Prothena Corp Public (PRTA) Current Deferred Revenue (2021 - 2025)
Historic Current Deferred Revenue for Prothena Corp Public (PRTA) over the last 5 years, with Q3 2025 value amounting to $2.7 million.
- Prothena Corp Public's Current Deferred Revenue fell 6959.92% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 6959.92%. This contributed to the annual value of $8.8 million for FY2024, which is N/A changed from last year.
- Latest data reveals that Prothena Corp Public reported Current Deferred Revenue of $2.7 million as of Q3 2025, which was down 6959.92% from $5.1 million recorded in Q2 2025.
- Over the past 5 years, Prothena Corp Public's Current Deferred Revenue peaked at $67.4 million during Q1 2024, and registered a low of $316000.0 during Q3 2023.
- Moreover, its 5-year median value for Current Deferred Revenue was $8.8 million (2022), whereas its average is $13.1 million.
- As far as peak fluctuations go, Prothena Corp Public's Current Deferred Revenue plummeted by 9673.05% in 2023, and later surged by 269493.67% in 2024.
- Quarter analysis of 5 years shows Prothena Corp Public's Current Deferred Revenue stood at $7.7 million in 2021, then soared by 49.43% to $11.4 million in 2022, then crashed by 97.24% to $316000.0 in 2023, then soared by 2700.63% to $8.8 million in 2024, then plummeted by 69.66% to $2.7 million in 2025.
- Its last three reported values are $2.7 million in Q3 2025, $5.1 million for Q2 2025, and $7.9 million during Q1 2025.